Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.99 USD | +0.11% | -5.71% | -21.88% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.88% | 2.15B | |
+17.18% | 83.07B | |
-28.48% | 70.89B | |
+5.28% | 28.32B | |
-7.44% | 17.73B | |
+1.89% | 17.43B | |
+2.10% | 15.64B | |
+7.02% | 13.46B | |
+64.96% | 12.69B | |
+6.88% | 12.82B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group Insider Sold Shares Worth $506,732, According to a Recent SEC Filing